Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration
May 03, 2024 01:57 ET
|
Novozymes A/S
For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA...
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
January 29, 2024 05:27 ET
|
Novozymes A/S
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...
Novozymes and Chr. Hansen announce name of future combined company; Novonesis
December 13, 2023 01:59 ET
|
Novozymes A/S
Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name...
Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations
October 26, 2023 02:01 ET
|
Novozymes A/S
After the first nine months of the 2023 financial year, Novozymes sees increasing demand for sustainable biosolutions and delivers 5% organic sales growth. The full-year organic sales growth outlook...
Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture and encouraging more consumers to choose plant-based alternatives
September 28, 2023 02:48 ET
|
Novozymes A/S
Novozymes is excited to offer Vertera® ProBite as a game-changing solution to the plant-based meat industry, opening up new possibilities to create today's and tomorrow's plant-based meat products...
Novozymes and Bactolife join forces to significantly reduce post weaning diarrhea and antibiotic use among weaner pigs
September 04, 2023 03:07 ET
|
Novozymes A/S
The two companies have signed a joint development and commercialization agreement to launch feed additive Ablacto+. The game changing biosolution uses binding proteins to stabilize the gut of...
Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook
August 09, 2023 01:59 ET
|
Novozymes A/S
After the first half of 2023, Novozymes sees overall stability in a volatile environment and delivers 3% organic sales growth. Following destocking and lower consumer demand, the organic full-year...
Novozymes delivers historically strong full-year results
January 26, 2023 02:01 ET
|
Novozymes A/S
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and...
Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
December 12, 2022 02:00 ET
|
Novozymes A/S
Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash...